Pharm prime vendor fleet
Ended Awarded
- Contract number
- SPE2DU26F0C12
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,158
Award facts
- Contract value 100% obligated
- $28,158.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $28,158 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, awarded on November 2, 2025, with completion targeted for November 3, 2025, represents a firm fixed-price procurement with no set-aside designation. DMS Pharmaceutical Group was selected to supply pharmaceutical products and medical consumables to support Department of Defense healthcare operations, leveraging the company's established capabilities as a critical supplier within the federal pharmaceutical supply chain.
This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The underlying IDC, valued at up to $500 million through December 31, 2036, authorizes the company to provide comprehensive pharmaceutical products including branded and generic prescription drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables to military healthcare facilities worldwide. DMS Pharmaceutical Group's selection as a regional prime vendor demonstrates its competitive capability in federal pharmaceutical procurement and positions the company as a key supplier for sustaining the Department of Defense's distributed medical supply requirements across global military healthcare operations.
Quick answers
Who was awarded contract SPE2DU26F0C12?
SPE2DU26F0C12 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 2, 2025.
How much is contract SPE2DU26F0C12 worth?
The government has obligated $28,158 on SPE2DU26F0C12.
Is contract SPE2DU26F0C12 an order under another contract?
Yes. SPE2DU26F0C12 is a delivery order under SPE2DU25D9815, an indefinite delivery contract.
Was contract SPE2DU26F0C12 competed?
The extent of competition for SPE2DU26F0C12 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award